drug protocol number

MO42921

drug sponsor

Hoffmann-La Roche Ltd

drug study

N/A

drug trial site

King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh)

drug status

Ongoing

drug phase